Skip to main content
Figure 6 | Cancer Cell International

Figure 6

From: Effects of suberoylanilide hydroxamic acid (SAHA) combined with paclitaxel (PTX) on paclitaxel-resistant ovarian cancer cells and insights into the underlying mechanisms

Figure 6

Annexin V-FITC/PI staining and flow cytometric analysis of apoptosis in OC3/P cells treated with SAHA or/and PTX. A: A1: Control, A2: 2 μM PTX, A3: 20 μM PTX, A4: 16 μM SAHA, A5: 16 μM SAHA + 2 μM PTX, A6: 16 μM SAHA + 20 μM PTX(methods as above); B: Percentages of apoptotic cells are displayed as the mean ± SD of three independent experiments performed in triplicate. *P <0.05 and **P <0.01, indicate significant differences compared with SAHA and PTX single-agent treatments.

Back to article page